AU6976300A - Methods for modulating cell proliferation - Google Patents

Methods for modulating cell proliferation

Info

Publication number
AU6976300A
AU6976300A AU69763/00A AU6976300A AU6976300A AU 6976300 A AU6976300 A AU 6976300A AU 69763/00 A AU69763/00 A AU 69763/00A AU 6976300 A AU6976300 A AU 6976300A AU 6976300 A AU6976300 A AU 6976300A
Authority
AU
Australia
Prior art keywords
methods
cell proliferation
modulating cell
modulating
proliferation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69763/00A
Inventor
Philip Barker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU6976300A publication Critical patent/AU6976300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/48—Nerve growth factor [NGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU69763/00A 1999-09-16 2000-09-15 Methods for modulating cell proliferation Abandoned AU6976300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15438199P 1999-09-16 1999-09-16
US60154381 1999-09-16
PCT/CA2000/001039 WO2001020335A2 (en) 1999-09-16 2000-09-15 Methods for modulating cell proliferation

Publications (1)

Publication Number Publication Date
AU6976300A true AU6976300A (en) 2001-04-17

Family

ID=22551139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69763/00A Abandoned AU6976300A (en) 1999-09-16 2000-09-15 Methods for modulating cell proliferation

Country Status (2)

Country Link
AU (1) AU6976300A (en)
WO (1) WO2001020335A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2892635B1 (en) 2005-10-28 2012-11-09 Engelhard Lyon SUBSTANCE FOR RESTORING NORMAL CO-EXPRESSION AND INTERACTION BETWEEN LOX AND NRAGE PROTEINS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780029A (en) * 1989-11-14 1998-07-14 New York Medical College Antidiotypic monoclonal antibodies for treatment of melanoma
WO1993015227A1 (en) * 1992-01-29 1993-08-05 Duke University Method of assaying for the oncogenic state of cells
NZ257181A (en) * 1992-10-29 1997-07-27 Medical Res Council Transcription factor dp-1, dna, vectors and host cells therefor

Also Published As

Publication number Publication date
WO2001020335A3 (en) 2001-10-04
WO2001020335A2 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
AU5170900A (en) Cell proliferation inhibitors
AU6005600A (en) Data distribution
AU6940300A (en) Self-spotting apparatus for free-weights
AU6731800A (en) Data distribution system
AU4416800A (en) Fibre-optics
AU5854100A (en) Lithium cell
AU6955100A (en) Battery
AU5043600A (en) Battery
AU1106401A (en) Battery
AU2832399A (en) B cell inhibitors
AU2433501A (en) Binding apparatus
AU4697600A (en) Methods for increasing t cell proliferation
AU4634300A (en) Nerve cell growth modulators (amphibodies)
AU5171600A (en) Battery
AU6179400A (en) Multi-photodetector unit cell
AU7638498A (en) Cyanoguanidines as cell proliferation inhibitors
AU2374601A (en) Delimbing apparatus
AU7854400A (en) Gestational agents which modulate cell proliferation
AUPQ314799A0 (en) Bone cell factor
AU2002335492A1 (en) Polynucleotide useful for modulating cancer cell proliferation
AU7957200A (en) Method for distributing pay-information
AU1082901A (en) Method for modulation of cell phenotype
AU6006800A (en) Treating cells
AU6976300A (en) Methods for modulating cell proliferation
AU1224200A (en) Methods for modulating cell fusion

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase